Skip to content
MedsAcross

Medicine

Rhophylac 1500 IU/2 mL injection

Human rho(d) immune globulin · Intramuscular, intravenous · CSL Behring
Available on requestPrescription onlyUS FDA Cold chain

Rhophylac 1500 IU/2 mL injection is a prescription medicine containing Human rho(d) immune globulin for intramuscular, intravenous use, marketed by CSL Behring, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store at 2 to 8°C (36 to 46°F) for a shelf life of 36 months from the date of…

Key facts

Active ingredient (INN)
Human rho(d) immune globulin
Brand
Rhophylac
Strength
1500 IU/2 mL
Dosage form
Injection
Route
Intramuscular, intravenous
Packs
1 syringe, 10 syringes
Marketing authorisation holder
CSL Behring
Manufacturer
CSL Behring
Origin register
US FDA, United States
Storage
Store at 2 to 8°C (36 to 46°F) for a shelf life of 36 months from the date of manufacture, as indicated by the expiration date printed on the outer carton and syringe label.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3002.12Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
6 January 2009
Identifiers
RxCUI 1117759, 1117765DailyMed set ID c1b5d801-336f-4541-a7d9-a8d4a110a4ccNDC 44206-300Application BLA125070

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 syringe, glass in 1 carton / 2 mL in 1 syringe, glass44206-300-01CSL Behring6 January 2009
10 syringe, glass in 1 carton / 2 mL in 1 syringe, glass44206-300-10CSL Behring6 January 2009

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Human rho(d) immune globulin

Clinical summary

Human rho(d) immune globulin is a human immunoglobulin G indicated for the suppression of Rh isoimmunization in non-sensitized Rh(D)-negative patients and for the treatment of immune thrombocytopenic purpura (ITP) in Rh(D)-positive patients. MedsAcross supplies Human rho(d) immune globulin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Human rho(d) immune globulin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Rhophylac 1500 IU/2 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.